Methods of treating and preventing colitis involving il-13 and nk-t cells
AssigneeThe USA, as represented by the Secretary, Department of Health and Human Service
InventorsWarren Strober, Ivan J. Fuss, Frank Heller, Richard S. Blumberg
Life of this patent
Estimating the term…
Abstract
Method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates IL-13 activity (FIG. 3). The invention also provides a method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates NK-T cell activity. The invention also provides for the screening of substances that treat or prevent the inflammatory response of colitis.
Claims23
1-37. (canceled)
A method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates NK-T cell activity.
39-41. (canceled)
(canceled)
47-48. (canceled)
50-51. (canceled)
A method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates IL-13 activity.
53-61. (canceled)
The method of claim 71, wherein the antibody binds to CD1.
63-65. (canceled)
69-70. (canceled)
72-84. (canceled)
Dependencies are inferred from the claim text.